PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26385607-5	2016	In this study, we aimed to investigate the effect of MART-10 and 1alpha,25(OH)2D3 on angiogenesis in vitro and in vivo.	25(oh)2d3	72-81	septin 4	Homo sapiens	53-57	
25149065-3	2014	Previously we have shown that vitamin D analog, MART-10 (19-nor-2alpha-(3-hydroxypropyl)-1alpha,25(OH)2D3), exerted potent antiproliferative effect on PDA in vitro and in vivo without causing hypercalcemia.	25(oh)2d3	96-105	septin 4	Homo sapiens	48-52	
24044969-6	2013	A new class of less-calcemic 1alpha,25(OH)2D3 analog, MART-10 (19-nor-2alpha-(3-hydroxypropyl)- 1alpha,25-Dihydroxyvitamin D3), has been shown to be much more potent than 1alpha,25(OH)2D3 in inhibiting cancer cell growth in vitro and in vivo without inducing hypercalcemia.	25(oh)2d3	36-45	septin 4	Homo sapiens	54-58	
24044969-6	2013	A new class of less-calcemic 1alpha,25(OH)2D3 analog, MART-10 (19-nor-2alpha-(3-hydroxypropyl)- 1alpha,25-Dihydroxyvitamin D3), has been shown to be much more potent than 1alpha,25(OH)2D3 in inhibiting cancer cell growth in vitro and in vivo without inducing hypercalcemia.	25(oh)2d3	178-187	septin 4	Homo sapiens	54-58